Why Consider Investing in 3D Printing Companies?
By Jocelyn Aspa
The potential of 3D printing technology, particularly in the medical space, has many people considering investing in 3D printing companies.
Your trusted source for investing success
Your trusted source for investing success
By Jocelyn Aspa
The potential of 3D printing technology, particularly in the medical space, has many people considering investing in 3D printing companies.
Nabriva Therapeutics plc saw its stock get a major boost on Monday morning after the company announced top-line results from their trial of a pneumonia drug.
CASI Pharmaceuticals, Savara, Adverum Biotechnologies, ChromaDex Therapeutics and MannKind top the NASDAQ biotech stock list.
The Investing News rounds some of the biggest news in the cannabis market for the past trading week
Soleno Therapeutics presented new efficacy data from the pilot clinical trial of Diazoxide Choline Controlled-Release Tablet treating Prader-Willi syndrome at the International Meeting of Pediatric Endocrinology.
The global stem cell therapy market is expected to grow at a CAGR of 36.52 percent between 2017 and 2021. Here are 10 top stem cell companies on the NASDAQ.
BriaCell Therapeutics provided an update on its collaborative and internal research as well as manufacturing activities.
Soleno Therapeutics announced the issuance of a new US patent from the related to the use of pharmaceutical formulations of diazoxide and its salts.
For those looking to avoid volatility, these biotechnology ETFs may be the ticket.
By Shelly Kumar
CanniMed Therapeutics Inc. (TSX:CMED) (“CanniMed” or the “Company”) today released its financial results for the three and nine months ended July 31, 2017.
Highlights
Sales of $4.8 million in the quarter were 80 per cent higher than in the comparable period of the prior year and were 29 per cent higher than the second quarter of 2017.
Opexa Therapeutics announced the recommendation it received for its shareholders from two advisory firms on matters related to their next meeting.
By Jocelyn Aspa
The Canadian marijuana sector is one of the hottest growing sectors. Here’s a look at Canadian cannabis companies for investors to consider.
By Jocelyn Aspa
Glance Technologies (CSE:GET.CN) has announced that its partially-owned subsidiary, Cannapay Financial, has entered into an agreement to acquire the rights to a package of holistic Ayurveda formulas intended to treat a number of ailments.
As quoted in the press release:
Cannapay has agreed to purchase all of the intellectual property pertaining to
Voyager Therapeutics announced positive results from their ongoing Phase 1b trial of VY-AADC01 in advanced Parkinson’s disease.
Oncology investing can certainly be intimidating. Here, the Investing News Network looks at companies in the space and other ways to invest.
Neovasc, Adaptimmune, Curis, Vericel and MannKind top the NASDAQ biotech stock list.
The Investing News reported took a closer look at some of the big cannabis news of the week and published an interview with the president of Cannabis Wheaton.
Dimension Therapeutics announced the start of patient dosing for their Phase 1/2 clinical trial to evaluate DTX301 for the treatment of patients with Ornithine Transcarbamylase deficiency.
Kalytera Therapeutics released their financial results for the second quarter of 2017.
VistaGen Therapeutics announced the pricing of an underwritten public offering of 1,371,430 shares of its common stock.
